Summary
Johnson & Johnson (JNJ) filed an 8-K on January 22, 2020, reporting its financial results for the fourth quarter and full year ended December 29, 2019. The filing primarily consists of a press release and supplementary financial data that detail the company's operational performance. Investors can find key metrics such as sales and earnings, which are crucial for assessing the company's profitability and growth trajectory over the reported periods. This report provides a snapshot of JNJ's financial health as it concluded the 2019 fiscal year. The information contained within the press release and supplementary schedules will enable investors to evaluate management's performance, compare results to prior periods and expectations, and make informed investment decisions regarding the company's future prospects.
Key Highlights
- 1Johnson & Johnson announced its fourth quarter and full year 2019 sales and earnings results.
- 2The filing includes a press release dated January 22, 2020, detailing the financial performance.
- 3Supplementary sales data and condensed consolidated statements of earnings for the respective periods are provided.
- 4The reported period concluded on December 29, 2019.
- 5This 8-K serves as the official channel for disseminating JNJ's key financial outcomes.
- 6Investors can refer to Exhibit 99.1 and 99.2 for detailed financial information.